FDA Clears Rapid Hyperdensity Tool for Inclusion in RapidAI Platform for Neurovascular Conditions - Neurology Live
7/21/2022 12:00:00 AM2 years 9 months ago
by Matt Hoffman
by Matt Hoffman
The Rapid Hyperdensity tool uses noncontrast CT scans to evaluate the hyperdense tissue volume during the identification and assessment of intracerebral hemorrhage.
The FDA has cleared a new tool for RapidAIs neurovascular artificial intelligence (AI) platform, called Rapid Hyperdensity, as part of the clinical decision support and patient workflow. Rapid Hyperd… [+4371 chars]
full article...